University of Rochester Medical Center

Oncology & Cancer

Pancreatic cancer discovery opens the door for new clinical trial

Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup. But, researchers made a breakthrough by learning about the genetic changes that occur during tumor ...

Oncology & Cancer

Genomic tug of war could boost cancer therapy

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant ...

Health informatics

Keeping a human in the loop: Managing the ethics of AI in medicine

Artificial intelligence (AI)—of ChatGPT fame—is increasingly used in medicine to improve diagnosis and treatment of diseases, and to avoid unnecessary screening for patients. But AI medical devices could also harm patients ...

Genetics

Should we screen all newborns for neurodevelopmental disorders?

Expanding newborn screening (NBS) to include identifying genes associated with an increased risk for neurodevelopmental disorders (NDD) would cause more harm than good, according to an article published in Pediatrics. While ...

Diseases, Conditions, Syndromes

Do I still need to worry about COVID?

Let's face it: We all want to move on from COVID-19. And with many of us vaccinated at some point, you might be wondering if it's time to let those pandemic worries go for good.

Cardiology

Racial disparities discovered in patients with cardiac devices

Black patients with implantable cardioverter defibrillators (ICDs) have a significantly higher burden of disease than white patients with the same device, according to a new study from University of Rochester Medical Center ...

page 2 from 40